Ondansetron Hydrochloride
Pruritus, Hyperemesis Gravidarum, Nausea + 8 more
Treatment
4 Active Studies for Ondansetron Hydrochloride
Treatment for
Pruritus
What is Ondansetron Hydrochloride
Ondansetron
The Generic name of this drug
Treatment Summary
Ondansetron is a drug that works by blocking certain serotonin receptors in the brain. It was approved by the FDA in 1991 and is available as a pill, a dissolving tablet, and an injection. It is used to prevent nausea and vomiting caused by chemotherapy, and has also been found to have calming and sedative effects. Recently, a new oral film form of ondansetron has been developed to make it easier for people experiencing nausea to take the medication.
Zofran
is the brand name
Ondansetron Hydrochloride Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Zofran
Ondansetron
1991
583
Effectiveness
How Ondansetron Hydrochloride Affects Patients
Ondansetron blocks the serotonin 5-HT<sub>3</sub> receptors in the body that are responsible for causing nausea and vomiting. Chemotherapy drugs can release serotonin from the intestines that trigger these symptoms, and ondansetron helps to counteract this. Studies have shown that taking ondansetron can lead to a slight increase in the time it takes for electrical signals to travel through the heart, but this effect has not been seen in those taking it orally. Additionally, it has been found to have no effect on esophageal and gastric motility, lower esophageal sph
How Ondansetron Hydrochloride works in the body
Ondansetron works by blocking a reflex in the body caused by serotonin. Serotonin is a chemical released from cells in the small intestine, which can cause nausea and vomiting. Ondansetron blocks this reflex by blocking the serotonin receptors, located on neurons in the peripheral and central nervous systems. While it seems to work for post-operative and chemotherapy-induced nausea and vomiting, it is not yet known how it affects opiate-induced emesis.
When to interrupt dosage
The prescribed dosage of Ondansetron Hydrochloride is contingent upon the diagnosed condition, such as Uremia, radiation therapy-induced nausea and vomiting and Pharmacotherapy. The quantity of dosage fluctuates, contingent upon the approach of delivery enumerated in the table below.
Condition
Dosage
Administration
Pharmacotherapy
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Uremia
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Pharmacotherapy
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Malignant Neoplasms
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Pruritus
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Hyperemesis Gravidarum
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
radiation therapy induced nausea and vomiting
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Malignant Neoplasms
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Tablet, film coated, Oral, Solution - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Film, soluble - Oral, Film, soluble, Solution - Intravenous, Tablet - Oral, Tablet, Solution, Liquid, Liquid - Intravenous, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular, Solution - Intramuscular; Intravenous, Film - Oral, Film
Warnings
Ondansetron Hydrochloride Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Ondansetron Hydrochloride.
Common Ondansetron Hydrochloride Drug Interactions
Drug Name
Risk Level
Description
Amitriptyline
Major
The metabolism of Amitriptyline can be decreased when combined with Ondansetron.
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Ondansetron.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Anagrelide.
Apomorphine
Major
The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Arsenic trioxide.
Ondansetron Hydrochloride Toxicity & Overdose Risk
There have been reports of some unusual side effects after taking large doses of ondansetron, such as temporary blindness, low blood pressure, and seizures. However, these reactions went away completely after treatment. Ondansetron has not been tested in pregnant women, so it is not recommended for use during pregnancy. Additionally, nursing mothers should not take ondansetron as it is not known if it is excreted in breast milk. There is also not enough information to provide dosage recommendations for children 3 years of age or younger.
Ondansetron Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Ondansetron Hydrochloride?
Two current clinical studies are investigating the potential of Ondansetron Hydrochloride in providing relief from Nausea, Uremia and Radiation Therapy induced Nausea and Vomiting.
Condition
Clinical Trials
Trial Phases
Hyperemesis Gravidarum
0 Actively Recruiting
Nausea
0 Actively Recruiting
radiation therapy induced nausea and vomiting
0 Actively Recruiting
Malignant Neoplasms
0 Actively Recruiting
Nausea
3 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Nausea
0 Actively Recruiting
Pruritus
0 Actively Recruiting
Pharmacotherapy
0 Actively Recruiting
Uremia
0 Actively Recruiting
Pharmacotherapy
1 Actively Recruiting
Not Applicable
Malignant Neoplasms
0 Actively Recruiting
Ondansetron Hydrochloride Reviews: What are patients saying about Ondansetron Hydrochloride?
5
Patient Review
2/21/2019
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
2/20/2018
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
11/19/2021
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
2/24/2020
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
3/5/2017
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
12/31/2019
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
10/28/2021
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
2/20/2018
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
8/27/2015
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
10/28/2021
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
11/19/2021
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
3/5/2017
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
2/21/2019
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
12/31/2019
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
1/4/2015
Ondansetron Hydrochloride for Prevent Nausea and Vomiting After Surgery
5
Patient Review
2/12/2015
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
3/24/2015
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
8/27/2015
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
2/12/2015
Ondansetron Hydrochloride for Prevent Nausea and Vomiting from Cancer Chemotherapy
5
Patient Review
3/24/2015
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
2/24/2020
Ondansetron Hydrochloride for Nausea and Vomiting
5
Patient Review
1/4/2015
Ondansetron Hydrochloride for Prevent Nausea and Vomiting After Surgery
4.7
Patient Review
3/8/2016
Ondansetron Hydrochloride for Nausea and Vomiting
4.7
Patient Review
3/8/2016
Ondansetron Hydrochloride for Nausea and Vomiting
4
Patient Review
7/18/2016
Ondansetron Hydrochloride for Nausea and Vomiting
4
Patient Review
7/18/2016
Ondansetron Hydrochloride for Nausea and Vomiting
2.3
Patient Review
9/30/2014
Ondansetron Hydrochloride for Nausea and Vomiting
2.3
Patient Review
9/30/2014
Ondansetron Hydrochloride for Nausea and Vomiting
2
Patient Review
2/16/2018
Ondansetron Hydrochloride for Nausea and Vomiting
2
Patient Review
10/18/2015
Ondansetron Hydrochloride for Nausea and Vomiting
2
Patient Review
2/16/2018
Ondansetron Hydrochloride for Nausea and Vomiting
2
Patient Review
10/18/2015
Ondansetron Hydrochloride for Nausea and Vomiting
1.7
Patient Review
4/6/2015
Ondansetron Hydrochloride for Nausea and Vomiting
1.7
Patient Review
4/6/2015
Ondansetron Hydrochloride for Nausea and Vomiting
Patient Q&A Section about ondansetron hydrochloride
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is ondansetron a painkiller?
"Zofran works by selectively blocking the action of serotonin, a naturally occurring substance in the body that may cause nausea and vomiting.
Zofran does not belong to the class of narcotic medications. Instead, it is a 5-HT3 receptor antagonist, which means that it blocks the action of serotonin. Serotonin is a naturally occurring substance in the body that can cause nausea and vomiting."
Answered by AI
What happens when you take ondansetron?
"Ondansetron prevents nausea and vomiting by blocking the action of chemicals in the body. It is used to prevent nausea and vomiting that may be caused by surgery, cancer chemotherapy, or radiation treatment."
Answered by AI
What is ondansetron hydrochloride used for?
"Ondansetron is a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery."
Answered by AI
How do you take ondansetron hydrochloride 4 mg?
"Put the film on top of your tongue, where it will dissolve. Do not chew or swallow it. Once it is dissolved, swallow with or without water."
Answered by AI